Randomized Double-Blind Placebo-Controlled Adaptive Design Trial of Intrathecally Administered Autologous Mesenchymal Stem Cells in Multiple System Atrophy

Medicine & Life Sciences

1. Multiple System Atrophy 100%
2. Mesenchymal Stem Cells 67%
3. Placebos 63%
4. Disease Progression 57%
5. Medical Futility 33%
6. Atrophy 20%
7. Injections 20%
8. Cauda Equina 16%
9. Biomarkers 15%
10. Ringer's Lactate 15%
11. Safety 13%
12. Subcutaneous Fat 13%
13. Intermediate Filaments 13%
14. Nerve Growth Factors 12%
15. Natural History 12%
16. Low Back Pain 11%
17. Random Allocation 11%
18. Arm 10%
19. Cultured Cells 10%
20. Research Design 9%
21. Spine 9%
22. Stem Cells 8%
23. Head 8%
24. Light 8%
25. Biopsy 7%
26. Survival 6%
27. Control Groups 6%
28. Therapeutics 5%